Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (231-240 of 418) with videos related to

Pageof 42
Sort By:
Journal of the National Cancer Institute|August 26, 2025
Censoring in trials testing immunotherapy in advanced cancers. A systematic review and a meta-research studyFilippo Vitale, Fabio Salomone, Massimo Di Maio, et al.
Biomedicines|August 28, 2025
The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target TherapyDaria Maria Filippini, Donatella Romaniello, Francesca Carosi, et al.
The Lancet Regional Health. Europe|March 13, 2024
New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across EuropeIlias Houda, Chris Dickhoff, Carin A Uyl-de Groot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panelCesare Gridelli, Matti Aapro, Andrea Ardizzoni, et al.
Critical Reviews in Oncology/Hematology|September 20, 2025
Quality of life results and survival outcomes in trials of immunotherapy in advanced cancers: A systematic review and meta-research studyAnnarita Avanzo, Fabio Salomone, Massimo Di Maio, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II studyCesare Gridelli, Antonio Rossi, Emiddio Barletta, et al.
In Vivo (Athens, Greece)|October 31, 2019
Women With Synchronous or Metachronous Lung and Ovarian Cancer: A Multi-Institutional ReportAnnapaola Mariniello, Eleonora Ghisoni, Luisella Righi, et al.
The Lancet. Oncology|September 19, 2014
Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient dataAntonio Rossi, Paolo Chiodini, Jong-Mu Sun, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 2024
Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effectsVittorio Fusco, Massimo Di Maio, Anna Amela Valsecchi, et al.
Clinical Lung Cancer|January 14, 2015
Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized TrialDomenico Galetta, Saverio Cinieri, Salvatore Pisconti, et al.
Pageof 42

Showing results (231-240 of 418) with videos related to

Sort By:
Pageof 42
Journal of the National Cancer Institute|August 26, 2025
Censoring in trials testing immunotherapy in advanced cancers. A systematic review and a meta-research studyFilippo Vitale, Fabio Salomone, Massimo Di Maio, et al.
Biomedicines|August 28, 2025
The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target TherapyDaria Maria Filippini, Donatella Romaniello, Francesca Carosi, et al.
The Lancet Regional Health. Europe|March 13, 2024
New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across EuropeIlias Houda, Chris Dickhoff, Carin A Uyl-de Groot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2005
Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panelCesare Gridelli, Matti Aapro, Andrea Ardizzoni, et al.
Critical Reviews in Oncology/Hematology|September 20, 2025
Quality of life results and survival outcomes in trials of immunotherapy in advanced cancers: A systematic review and meta-research studyAnnarita Avanzo, Fabio Salomone, Massimo Di Maio, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II studyCesare Gridelli, Antonio Rossi, Emiddio Barletta, et al.
In Vivo (Athens, Greece)|October 31, 2019
Women With Synchronous or Metachronous Lung and Ovarian Cancer: A Multi-Institutional ReportAnnapaola Mariniello, Eleonora Ghisoni, Luisella Righi, et al.
The Lancet. Oncology|September 19, 2014
Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient dataAntonio Rossi, Paolo Chiodini, Jong-Mu Sun, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 2024
Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effectsVittorio Fusco, Massimo Di Maio, Anna Amela Valsecchi, et al.
Clinical Lung Cancer|January 14, 2015
Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized TrialDomenico Galetta, Saverio Cinieri, Salvatore Pisconti, et al.
Pageof 42